Is Veeda Clinical Research a good quality company?

Data is not available for this company.

What is Veeda Clinical Research share price return in the past 10 years?

Data is not available for this company

Veeda Clinical Research Ltd - Stock Valuation and Financial Performance

Name: Veeda Clinical Research
Brand: Veeda Clinical Research

BSE: 0 | NSE: | Hospital & Healthcare Services | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Veeda Clinical Research

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Veeda Clinical Research:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	3.2%	-59%	21.3%	26.1%	57.7%	78.1%	5.9%	60.5%	8.9%	8.5%	-
Value Creation Index ⓘ	-0.8	-5.2	0.5	0.9	3.1	4.6	-0.6	3.3	-0.4	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	43.3	63.1	97	131	182	218	151	196	224	296	196
Sales YoY Gr.	-	45.7%	53.7%	34.9%	39.4%	19.7%	-30.8%	29.4%	14.4%	32.3%	-
Adj EPS ⓘ	0.1	-2.8	1.7	3	9.3	14.7	0.1	10.5	3.2	4.4	13.7
YoY Gr.	-	-4028.6%	NA	78.2%	207.6%	57.6%	-99.5%	12987.5%	-69.2%	35.3%	-
BVPS (₹) ⓘ	19.5	6.5	8.2	11.3	20.7	15.4	15	37.1	89.1	94	52
Adj Net Profit ⓘ	0.2	-9.1	5.6	10	30.6	51.8	0.3	37.8	17.1	23.1	63
Cash Flow from Ops. ⓘ	7.1	19.4	14.6	7	24.9	75.2	9.1	76.6	12.7	75.1	-
Debt/CF from Ops. ⓘ	0.9	0.4	0.9	2.9	0.6	0.1	1.8	0.3	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	23.8%	10.2%	25.1%	32.3%
Adj EPS ⓘ	58.3%	-14.1%	279.4%	35.3%
BVPSⓘ	19.1%	35.4%	84.4%	5.5%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	0.3	-15.1	13.6	20.3	44.1	59.3	0.3	29.3	5.3	4.7	18.7
Op. Profit Mgn % ⓘ	11.2	21.6	19	17.5	33	37.7	13.8	34.1	18.3	19	NAN
Net Profit Mgn % ⓘ	0.5	-14.3	5.8	7.6	16.8	23.7	0.2	19.3	7.6	7.8	32.3
Debt to Equity ⓘ	0.1	0.2	0.3	0.4	0.2	0.1	0.2	0.1	0	0	-
Working Cap Days ⓘ	204	135	136	139	124	110	171	186	238	223	0
Cash Conv. Cycle ⓘ	85	61	48	37	39	46	80	56	77	67	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Veeda Clinical Research Ltd.

	Standalone	Consolidated
TTM EPS (₹)	13.7	0
TTM Sales (₹ Cr.)	196	0
BVPS (₹.) ⓘ	52	2
Reserves (₹ Cr.) ⓘ	231	-
P/BV ⓘ	0.00	0.00
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	9.3
Face Value (₹)	2
Industry PE ⓘ	43.2

Management X-Ray of Veeda Clinical Research:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Veeda Clinical Research

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Veeda Clinical Research

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	43.32	63.12	97.02	130.85	182.45	218.44	151.27	195.81	223.93	296.15
Operating Expenses ⓘ	38.46	49.47	78.64	107.95	122.18	136.14	131.89	129.10	182.85	241.74
Manufacturing Costs	11.76	17.16	28.11	38.51	45.50	47.15	47.65	49.54	80.05	115.85
Material Costs	4.64	6.40	10.35	13.30	15.47	14.33	13.29	13.95	18.83	17.81
Employee Cost	12.12	13.46	20.69	31.38	34.99	43.60	54.33	49.17	63.58	74.05
Other Costs ⓘ	9.94	12.45	19.48	24.76	26.22	31.05	16.62	16.43	20.39	34.02
Operating Profit ⓘ	4.86	13.65	18.38	22.90	60.27	82.31	19.39	66.72	41.08	54.42
Operating Profit Margin (%)	11.2%	21.6%	18.9%	17.5%	33.0%	37.7%	12.8%	34.1%	18.3%	18.4%
Other Income ⓘ	1.53	1.18	1.43	5.57	0.78	5.34	2.41	38.57	4.23	9.15
Interest ⓘ	1.38	1.12	1.64	2.64	2.70	2.38	5.09	4.81	4.58	5.33
Depreciation ⓘ	3.48	5.66	8.85	11.26	10.58	9.44	15.80	14.95	15.53	21.13
Exceptional Items ⓘ	0	-48.24	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1.52	-40.19	9.33	14.58	47.77	75.82	0.90	85.53	25.20	37.10
Tax ⓘ	0.67	2.62	3.48	4.63	16.86	23.20	0.94	22.25	6.87	11.15
Profit After Tax	0.85	-42.82	5.85	9.96	30.91	52.62	-0.04	63.29	18.33	25.95
PAT Margin (%)	2.0%	-67.8%	6.0%	7.6%	16.9%	24.1%	0.0%	32.3%	8.2%	8.8%
Adjusted EPS (₹)	0.3	-13.0	1.8	3.0	9.4	7.6	0.0	17.6	3.5	4.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	66%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	81.24	38.28	44.13	54.08	85	89.51	88	169.17	471.34	497.04
Share Capital ⓘ	17.59	17.59	17.59	17.59	17.59	35.82	35.82	35.83	10.58	10.58
Reserves ⓘ	63.66	20.69	26.54	36.50	67.41	53.69	52.18	133.34	460.77	486.46
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	4.16	4.39	9.63	13.76	10	4.88	16.69	24.32	0	0
Long Term Debt	2.13	4.39	9.46	12.99	10	0	0	0	0	0
Short Term Debt	2.03	0	0.18	0.78	0	4.88	16.69	24.32	0	0
Trade Payables	2.27	2.84	7.53	9.31	7.92	11.21	8.74	12.33	21.48	19.19
Others Liabilities ⓘ	8.85	20.30	34.64	24.40	22.77	23.56	62.60	73.50	97.09	135.88
Total Liabilities ⓘ	96.52	65.81	95.93	101.56	125.68	129.17	176.04	279.31	589.91	652.11
Fixed Assets
Gross Block	48.27	60.74	85.27	99.68	108.65	111.91	107	118.63	115.76	170.62
Accumulated Depreciation	28.45	34.25	43	54.25	64.72	74.16	29.34	44.28	46.07	64.89
Net Fixed Assetsⓘ	19.82	26.49	42.27	45.43	43.92	37.75	77.66	74.36	69.70	105.72
CWIP ⓘ	2.59	0.12	2.90	0.31	0.59	7.74	0.51	1.13	10.21	8
Investmentsⓘ	51.16	3.05	2.80	0.14	2.75	1.77	0	66.87	276.86	291.17
Inventories	1.65	2.54	4.18	4.23	4.98	4.73	4.78	5.66	6.99	4.90
Trade Receivables	10.32	13.51	19.34	21.72	37.56	43.63	36.05	45.15	77.39	71.14
Cash Equivalents	1.79	10.47	1.61	2.03	8.13	20.12	17.57	17.81	60.67	57.72
Others Assetsⓘ	9.18	9.65	22.82	27.70	27.74	13.43	39.48	68.33	88.09	113.46
Total Assets ⓘ	96.52	65.81	95.93	101.56	125.68	129.17	176.04	279.31	589.91	652.11

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	7.13	19.42	14.58	6.96	24.89	75.23	9.13	76.63	12.73	75.06
PBT ⓘ	1.52	-40.19	9.33	14.58	47.77	75.82	0.90	85.53	25.20	37.10
Adjustment ⓘ	4.31	54.49	10.37	13.03	12.94	8.24	19.66	18.34	20.90	32.45
Changes in Working Capital ⓘ	2.01	8.56	-0.22	-13.67	-18.57	14.19	-2.29	-4.22	-21.41	19.07
Tax Paid ⓘ	-0.71	-3.44	-4.90	-6.99	-17.26	-23.03	-9.14	-23.03	-11.96	-13.55
Cash Flow From Investing Activity ⓘ	-0.93	-15.58	-21.09	-8.37	-11.96	-8.63	-9.03	-92.58	-141.83	-106.71
Capex	-3.38	-10.01	-27.40	-11.83	-9.38	-10.12	-9.06	-3.95	-11.94	-46.22
Net Investments	0	0	0	0	-2.93	1.76	-0.47	-65.76	-62	-45
Others ⓘ	2.44	-5.57	6.31	3.46	0.34	-0.28	0.50	-22.87	-67.89	-15.48
Cash Flow From Financing Activityⓘ	-6.60	-0.89	3.60	1.48	-6.46	-55.57	-3.45	17.07	172.10	8.15
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	17.99	230.08	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	-5.42	0	0	0
Interest Paid ⓘ	-1.38	-1.12	-1.64	-2.66	-2.70	-2.43	-0.98	-0.76	-4.58	-5.24
Dividend Paid ⓘ	0	0	0	0	0	-31.27	0	0	-12.08	0
Others ⓘ	-5.22	0.23	5.24	4.13	-3.77	-21.88	2.95	-0.16	-41.33	13.39
Net Cash Flow ⓘ	-0.41	2.95	-2.91	0.06	6.46	11.02	-3.35	1.11	43	-23.49

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	1.33	-100.22	24.2	31.05	58.88	86.1	-0.08	67.8	6.06	5.36
ROCE (%)	3.23	-58.95	21.33	26.12	57.73	78.05	5.86	60.47	8.92	8.53
Asset Turnover Ratio	0.43	0.78	1.2	1.33	1.61	1.71	0.99	0.86	0.52	0.48
PAT to CFO Conversion(x)	8.39	N/A	2.49	0.7	0.81	1.43	N/A	1.21	0.69	2.89
Working Capital Days
Receivable Days	108	69	62	57	59	68	96	76	100	92
Inventory Days	14	12	13	12	9	8	11	10	10	7
Payable Days	260	145	183	231	203	244	274	276	328	417

Veeda Clinical Research Ltd Stock News

Veeda Clinical Research Ltd FAQs

What is the share price of Veeda Clinical Research?

Company share prices are keep on changing according to the market conditions. The closing price of Veeda Clinical Research on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Veeda Clinical Research?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Veeda Clinical Research stood at ₹0.00.